Literature DB >> 28328340

Selumetinib in Plexiform Neurofibromas.

Andrea Gross1, Rachel Bishop2, Brigitte C Widemann3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28328340     DOI： 10.1056/NEJMc1701029

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Current status of MEK inhibitors in the treatment of plexiform neurofibromas.

Authors:  Andrea M Gross; Eva Dombi; Brigitte C Widemann
Journal:  Childs Nerv Syst       Date:  2020-06-30       Impact factor: 1.475

2.  Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression.

Authors:  Jamie Zagozewski; Stephanie Borlase; Brent J Guppy; Ludivine Coudière-Morrison; Ghazaleh M Shahriary; Victor Gordon; Lisa Liang; Stephen Cheng; Christopher J Porter; Rhonda Kelley; Cynthia Hawkins; Jennifer A Chan; Yan Liang; Jingjing Gong; Carolina Nör; Olivier Saulnier; Robert J Wechsler-Reya; Vijay Ramaswamy; Tamra E Werbowetski-Ogilvie
Journal:  Commun Biol       Date:  2022-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.